The latest news from academia, regulators
research labs and other things of interest
Posted: October 7, 2008
Particle Sciences Sells Its Line of Microfine Titanium Dioxides to Sensient
(Nanowerk News) Particle Sciences announced today
that it has sold T-COTE, its proprietary line of microfine titanium dioxide,
to Sensient. With the sale, Sensient assumes all marketing and sales
responsibilities and acquires the associated trademarks and existing business.
Particle Sciences will remain involved during the transition for technical
support. The sale does not result in any change to the product, its
specifications or method and location of manufacture.
Particle Science's has been a pioneer in nanotechnology. Its staff
invented, among other things, Z-COTE, microfine zinc oxide, a product that was
sold to BASF in 1999. These pigments are primarily used as sunscreens.
Particle Sciences also developed several surface treatments for these and
other particles. "Particle Sciences has been at the cutting edge of fine
particle technology for some time. We have a history of developing
commercially successful products for ourselves and others," said Garry Gwozdz,
Director of Formulation Services at the company.
The sale is in keeping with Particle Sciences growth plan as it focuses on
its pharmaceutical development services. According to Dr. Robert Lee, VP
Pharmaceutical Development, "Particle Sciences started, in 1991, as a topical
formulation lab specializing in particulate API's. It has evolved into a
leading provider of pharmaceutical development services ranging from
preformulation to encapsulation to clinical trial material manufacturing. We
remain expert in nano-delivery systems and provide a full suite of formulation
and analytical services to our clients."
About Particle Sciences
Particle Sciences is an integrated provider of drug development services.
Particle Sciences focuses on emulsions, gels, particulates and drug/device
combination products with additional specialized capabilities in topical and
mucosal drug delivery. Through a full range of formulation, analytic, and
manufacturing services, Particle Sciences provides pharmaceutical companies
with a complete and seamless development solution that minimizes the time and
risk between discovery and the clinic. The company was founded in 1991 and is
headquartered in Bethlehem, Pennsylvania.